The division of bioinformatics and biostatistics (DBB) requires service to sequence 95 genomic deoxyribonucleic acid (DNA) samples derived from drug-induced liver injury patients for protocol…
Ended Purchase Order Awarded
- Contract number
- 75F40124P00059
- Awardee
-
Ste&P Research LLC UEI J5J8KBH3AQ34
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $23,370
Award facts
- Contract value 33% obligated
-
- $23,370.00 Current, with exercised options
- $70,110.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 6 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Jefferson, AR 72079, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services Food and Drug Administration awarded a $70,110 firm fixed price purchase order to Ste&P Research LLC, doing business as Seqpal, to sequence 95 genomic DNA samples derived from drug-induced liver injury patients. This supports Protocol E0779001 under the Division of Bioinformatics and Biostatistics to identify genetic and nongenetic factors associated with individual susceptibility. Performance will occur in Jefferson, Arkansas through February 2027. The award was made to a self-certified small disadvantaged business without a set-aside designation. This work will provide genomic sequencing data to aid the FDA's analysis of factors influencing individual responses to drug toxicity as part of its efforts to ensure drug safety.
Description
The division of bioinformatics and biostatistics (DBB) requires service to sequence 95 genomic deoxyribonucleic acid (DNA) samples derived from drug-induced liver injury patients for protocol E0779001, identify genetic and nongenetic factors with INC
Quick answers
Who was awarded contract 75F40124P00059?
75F40124P00059 was awarded to Ste&P Research LLC by Food and Drug Administration (Department of Health and Human Services) on February 6, 2024.
How much is contract 75F40124P00059 worth?
The government has obligated $23,370 on 75F40124P00059. Its potential value, with all options, is $70,110.
Was contract 75F40124P00059 competed?
The extent of competition for 75F40124P00059 was competed under sap. The government received 6 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award